Библиография


Ramello A; Vitale C, Marangella, M Epidemiology of nephrolithiasis. J Nephrol 2000: 13(suppl 3): S45–S50.

Bushinsky DA. Recurrent hypercalciuric nephrolithiasis–does diet help? N Engl J Med,2002;  346(2):124–125.

Pak CY, Kidney stones, Lancet. 1998; 351(9118): 1797–1801.

Menon M, Parulkar BG, Drach GW, Urinary lithiasis etiology, diagnosis and medical management. In: Walsh P, Retik AB, Vaughan ED Jr, et ai, eds Campbell’sUrology, 7th ed. Philadelphia, Pa: WB Saunders, 1998:2659 – 2733.

Rivers K, Shetty S, Menon M. When and how to evaluate a patient with nephrolithiasis, Urol Clin North Am, 2000; 27(2):203–213.

Tieder M, Madej O, Shaked U, et al, “Idiopathic” hypercalciuria and heredi¬tary hypophosphatemic rickets, Two phenotypical expressions of a common genetic defect. N Engl J Med, 1987; 316(3):125–129.

Lloyd SE, Pearce SH, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature. 1996, 379 (6564)445–449.

Borghi L, Schianchi T, Meschi T, et al. Companson of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Enql J Med. 2002; 346(2):77–84.

Pak CY, Peters P, Hurt G, et al, Is selective therapy of recurrent nephrolithiasis possible? Am J Med. 1981 ;71(4)615–622.

Thomas JM, Cranston O, Knox AJ, Hyperparathyroidism — patterns of presentation, symptoms and response to operation. Ann R Coll Surg Engl 1985; 67(2):79–82.

Danpure CJ. Molecular and cell biology of primary hyperoxaluria type 1. Clin Investig. 1994:72(9):725–727.

Watts RW, Morgan SH, Danpure CJ, et al Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med, 1991; 90(2):179–188.

Menon M. Calcium oxalate renal lithiasis: endocrinology and metabolism In: Rajfer J, ed, Urologic Endocrinology. Philadelphia, Pa: WB Saunders 1986:386–407,

Robertson WG, Hughes H. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis—new evidence from studies in the Arabian Peninsula. Scanning Microsc. 1993; 7(1 ):391–402,

Baggio B, Gambaro G, Marchini F, et al. An inheritable anomaly of red cell oxalate transport in “primary” calcium nephrolithiasis correctable with diuretics. New Engl J Med 1986; 314(10):599–604,

Sidhu H, Schmidt ME, Cornelius JG, at al. Direct correlation between hyperoxaluria/oxalate stone disease end the absence of the gastrointestinal tract—dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol. 1999; 10(suppl 14): S334–S340

Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978, 13(5): 418–426

Gutman AB, Yu TF. Uric acid nephrolithiasis. Am J Med. 1968; 45(5): 756–779.

Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974;291(25):1344–1350.

Menon M, Mahle CJ. Urinary citrate excretion in patients with renal calculi. J Urol. 1983; 129(6): 1158–1160.

Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20(6): 371–377.

Lindberg JS, Zobitz MM, Poindexter JR, et al. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990: 9( 1): 48–55.

Caruana RJ, Buckalew VM Jr. The syndrome of distal (type 1) renal tubu¬lar acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltimore) 1988; 67(2):84–99.

Rocher LL, Tannen RL .The clinical spectrum of renal tubular acidosis. Annu Rev Med. 1986; 37: 319–331.

Goldfarb DS, Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician 1999; 60(8): 2269–2276.

Baynes JW, Dominiczak MH. Medical Biochemistry. Second edition. Elsevier Mosby 2005.

към началото